PVR and Miyoshi myopathy: It is interesting to point out that we have provided results demonstrating that the SUMO pathway regulates PVR expression in tumors other than MM, suggesting that PVR SUMOylation is a more general strategy to prevent DNAM1-dependent recognition and killing by NK cells.